News

Cambridge-based AI for materials science company CuspAI has confirmed a $100 million+ Series A round – led by global ...
Cambridge’s two universities and three NHS trusts have joined forces to find new industry partners to help them invent, test ...
Cambridge biopharma company Alchemab Therapeutics has raised an additional $32 million to help advance its portfolio and has ...
Cambridge superchip architect Arm reveals that Telechips, a global fabless semiconductor manufacturer specialising in ...
Lithuanian multiomics data analysis pioneer VUGENE reveals that its Chief Scientific Officer, Ingrida Olendraitė, is ...
Cambridge University researchers have developed a material that can sense tiny changes within the body, such as during an ...
The Milner Therapeutics Institute in Cambridge, headed by Professor Sir Tony Kouzarides and Dr Cathy Tralau-Stewart, has made ...
Cambridge based pharma company Bicycle Therapeutics has onboarded two experienced new directors as it inches closer to ...
Law firm Birketts, which has a major presence across the East of England, has appointed two new partners, enhancing its ...
NRG Therapeutics, a neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, has closed an ...
A new event at this year’s Cambridge Tech Week Fringe will see several of the UK’s most innovative fintech and insurtech ...
University of Cambridge spin-out and materials innovation pioneer Xampla has raised $14 million to fast-track its mission to ...